Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.55 |
| ▸ | CTSD | P07339 | 3/20 | 0.55 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | CASP9 | P55211 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 3/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10051906 | 0.87 | SYK (0.54) | CASP3CTSKKLK5BACE1CTSS | |
| SCHEMBL11911350 | 0.87 | SYK (0.54) | CASP3CTSKKLK5BACE1CTSS | |
| SCHEMBL30902853 | 0.87 | CTSD (0.45) | RENCTSDPSMB5CTSKCTSS | |
| SCHEMBL10051910 | 0.86 | REN (0.58) | RENCTSDCASP3CTSKCTSB | |
| SCHEMBL25054179 | 0.84 | CTSK (0.64) | PSMB5CTSKCTSBCTSS | |
| SCHEMBL17109073 | 0.84 | CTSK (0.59) | RENCTSKCTSBBACE1CTSS | |
| SCHEMBL29202512 | 0.84 | CTSK (0.64) | PSMB5CTSKCTSBCTSS | |
| SCHEMBL15083094 | 0.82 | ACE (0.49) | PSMB5CTSKKLK5CTSS | |
| SCHEMBL23156955 | 0.82 | ACE (0.49) | PSMB5CTSKKLK5CTSS | |
| SCHEMBL7326125 | 0.82 | ACE (0.66) | RENCTSDCTSKCTSBKLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105205-A1 | ANTIBODY-DRUG CONJUGATES (A2DCS) WITH ENZYMATICALLY CLEAVABLE GROUPS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-23 | — | — | WO | disclosed |